UnitedHealth Group (NYSE:UNH) Releases FY 2026 Earnings Guidance

UnitedHealth Group (NYSE:UNH) updated its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 19.500-20.000 for the period, compared to the consensus earnings per share estimate of 18.370. The company issued revenue guidance of -, compared to the consensus revenue estimate of $444.2 billion.

UnitedHealth Group Stock Up 0.7%

UNH stock opened at $426.39 on Friday. The firm has a market cap of $387.23 billion, a PE ratio of 27.44, a PEG ratio of 1.58 and a beta of 0.62. UnitedHealth Group has a one year low of $234.60 and a one year high of $461.62. The firm’s 50 day moving average price is $404.81 and its 200-day moving average price is $342.28. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.80 and a current ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm’s revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities research analysts anticipate that UnitedHealth Group will post 19.75 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio is currently 70.09%.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Weiss Ratings raised UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 10th. Erste Group Bank raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, April 27th. Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Piper Sandler set a $477.00 target price on shares of UnitedHealth Group in a research report on Thursday. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $447.29.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. The trade was a 4.30% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.28% of the company’s stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth beat Q2 estimates on earnings and revenue, driven by improved margins and lower medical costs, and raised its 2026 profit outlook. UnitedHealth shares surge on strong earnings beat and guidance
• Positive Sentiment: Morgan Stanley, Oppenheimer, UBS, RBC, and other firms lifted price targets after the results, signaling stronger Street confidence in the stock’s recovery. Analyst price target updates
• Positive Sentiment: Management doubled the 2026 share repurchase target to at least $5 billion, which may help support EPS and investor returns. What’s Fueling UNH Stock’s Rally? A Bigger Buyback, Higher Guidance – And CEO Says Turnaround Is ‘Returning To Form’
• Neutral Sentiment: Commentary around the earnings call says Medicare Advantage and Optum are improving, but commercial cost pressures could delay a full margin recovery. UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
• Negative Sentiment: Some analysts remain cautious, with at least one downgrade noting that the turnaround still faces execution risk despite the stronger quarter. UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)

Hedge Funds Weigh In On UnitedHealth Group

Institutional investors and hedge funds have recently bought and sold shares of the company. Sunbelt Securities Inc. increased its stake in UnitedHealth Group by 4.9% in the fourth quarter. Sunbelt Securities Inc. now owns 1,416 shares of the healthcare conglomerate’s stock valued at $467,000 after purchasing an additional 66 shares in the last quarter. Mcguire Capital Advisors Inc. bought a new stake in UnitedHealth Group during the fourth quarter valued at $40,000. Compound Planning Inc. boosted its position in shares of UnitedHealth Group by 10.5% during the 4th quarter. Compound Planning Inc. now owns 9,744 shares of the healthcare conglomerate’s stock valued at $3,217,000 after acquiring an additional 927 shares during the last quarter. Axxcess Wealth Management LLC lifted its position in UnitedHealth Group by 3.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 18,902 shares of the healthcare conglomerate’s stock valued at $6,240,000 after purchasing an additional 611 shares during the last quarter. Finally, Corient Private Wealth LLC increased its holdings in shares of UnitedHealth Group by 4.8% in the 4th quarter. Corient Private Wealth LLC now owns 431,657 shares of the healthcare conglomerate’s stock worth $142,494,000 after buying an additional 19,606 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.